• How do recent systemic approvals influence treatment selection for patients with psoriatic disease?​

  • Aug 9 2024
  • Durata: 25 min
  • Podcast

How do recent systemic approvals influence treatment selection for patients with psoriatic disease?​

Ascolta gratuitamente

Vedi i dettagli del titolo

  • Riassunto

  • During the Psoriasis Hub Steering Committee Meeting in May 2024, key opinion leaders met to discuss the current treatment landscape for patients with psoriasis and PsA.

    The recorded discussion was chaired by Paolo Gisondi, and featured Alice Gottlieb and Yukari Okubo. The steering committee discussed recent approvals of systemic agents for psoriatic disease, including efficacy and safety data of bimekizumab and deucravacitinib. They also spoke about how to avoid and treat oral candidiasis infections in patients treated with interleukin 17 inhibitors.


    Hosted on Acast. See acast.com/privacy for more information.
    Mostra di più Mostra meno
activate_samplebutton_t1

Cosa pensano gli ascoltatori di How do recent systemic approvals influence treatment selection for patients with psoriatic disease?​

Valutazione media degli utenti. Nota: solo i clienti che hanno ascoltato il titolo possono lasciare una recensione

Recensioni - seleziona qui sotto per cambiare la provenienza delle recensioni.

Recensioni da Audible.it

Recensioni da Amazon
Non ci sono recensioni disponibili